Thomas Burke
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 17, 2025
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab.L Johnetta Blakely, Sabine Oskar, Ian Kudel
|Jan 25, 2022
Indirect comparison of pembrolizumab monotherapy versus nivolumab + ipilimumab in first-line metastatic lung cancer.Balazs Halmos, Thomas Burke, Chrysostomos Kalyvas
|Aug 20, 2021
Augmenting Real-World Data Through Modeling Key Clinical Trial Eligibility Criteria: An Example of Patients With Non-small-Cell Lung Cancer Treated With Pembrolizumab.Thomas Jemielita, Xiaoyun Nicole Li, Thomas Burke
|May 26, 2021
Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel.Sarah Sharman Moser, Lior Apter, Ashwini Arunachalam
Pageof 1
Frequent Collaborators
1 joint publications
Sarah Sharman Moser
1 joint publications
Ashwini Arunachalam
1 joint publications
Varda Shalev
1 joint publications
Gabriel Chodick
1 joint publications
Nava Siegelmann-Danieli
1 joint publications
Thomas Jemielita
1 joint publications
Cong Chen
1 joint publications
Balazs Halmos
1 joint publications
Andrew Frederickson
1 joint publications
L Johnetta Blakely
